Inovio Pharmaceuticals (INO)
(Delayed Data from NSDQ)
$7.22 USD
-0.10 (-1.37%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $7.20 -0.02 (-0.28%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Earnings News For INO
-
Inovio: Q2 Earnings Snapshot
-
INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights
-
Inovio: Q1 Earnings Snapshot
-
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
-
Inovio: Q3 Earnings Snapshot
-
INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights
-
Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates
-
Inovio: Q2 Earnings Snapshot
-
Inovio Pharmaceuticals (INO) Reports Q1 Loss, Misses Revenue Estimates
-
Inovio: Q1 Earnings Snapshot
-
INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights
-
Inovio Pharmaceuticals (INO) Reports Q4 Loss, Lags Revenue Estimates
-
INOVIO Reports Fourth Quarter and Full Year 2022 Financial Results and Clinical Highlights
-
Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates
-
Inovio: Q3 Earnings Snapshot
-
INOVIO Reports Financial Results and Highlights for the Third Quarter 2022
-
Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates
-
Inovio: Q2 Earnings Snapshot
-
Inovio Pharmaceuticals (INO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Inovio Pharmaceuticals (INO) Reports Q1 Loss, Lags Revenue Estimates
-
Inovio Pharmaceuticals (INO) Reports Q4 Loss, Tops Revenue Estimates
-
Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates
-
Analysts Estimate Inovio Pharmaceuticals (INO) to Report a Decline in Earnings: What to Look Out for
-
Inovio Pharmaceuticals (INO) Reports Q2 Loss, Misses Revenue Estimates